For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Solketal is a protected form of glycerol with an isopropylidene acetal group joining two neighboring hydroxyl groups. Solketal contains a chiral center on the center carbon of the glycerol backbone, and so can be purchased as either the racemate or as one of the two enantiomers. Solketal has been used extensively in the synthesis of mono-, di- and triglycerides by ester bond formation. The free hydroxyl groups of solketal can be esterified with a carboxylic acid to form the protected monoglyceride, where the isopropylene group can then be removed using an acid catalyst in aqueous or alcoholic medium. The unprotected diol can then be esterified further to form either the di- or triglyceride.
Scope of the Report:
Solketal is widely used as organic solvent, plasticizer and pharmaceutical intermediates. In the application segment, Solvent segment accounted for the most of market share (74.37% in 2018), in terms of volume, while Pharmaceutical Intermediates segment accounted for 7.89%. Briefly speaking, in the next few years, Solketal industry will still be a highly energetic industry. With the global improvement of environmental protection concept, Solketal market will witness a significant increase.
The worldwide market for Solketal (CAS 100-79-8) is expected to grow at a CAGR of roughly -7.0% over the next five years, will reach 16 million US$ in 2024, from 23 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Solketal (CAS 100-79-8) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- Solvay
- Loba Feinchemie AG
- CM Fine Chemical
- Chemos GmbH
- Suzhou ChonTech BioPharma
- Beyond Industries
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Purity=96%
- 96%=Purity=98%
- Purity=98%
Market Segment by Applications, can be divided into
- Pharmaceutical Intermediates
- Solvent
- Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Solketal (CAS 100-79-8) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Solketal (CAS 100-79-8), with price, sales, revenue and global market share of Solketal (CAS 100-79-8) in 2017 and 2018.
Chapter 3, the Solketal (CAS 100-79-8) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Solketal (CAS 100-79-8) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Solketal (CAS 100-79-8) market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Solketal (CAS 100-79-8) sales channel, distributors, customers, research findings and conclusion, appendix and data source.